Fidelity Select Biotechnology Portfolio (FBIOX)

Fund Assets	6.03B
Expense Ratio	0.602%
Min. Investment	$0.00
Turnover	45.00%
Dividend (ttm)	0.44
Dividend Yield	1.52%
Dividend Growth	92.98%
Payout Frequency	Semi-Annual
Ex-Dividend Date	Apr 10, 2026

Previous Close	28.25
YTD Return	20.22%
1-Year Return	32.34%
5-Year Return	46.98%
52-Week Low	23.35
52-Week High	31.72
Beta (5Y)	0.55
Holdings	239
Inception Date	Dec 16, 1985

About FBIOX

The fund invests primarily in common stocks. It normally invests at least 80% of assets in securities of companies principally engaged in the research, development, manufacture, and distribution of various biotechnological products, services, and processes and companies that benefit significantly from scientific and technological advances in biotechnology. The fund invests in domestic and foreign issuers. It uses fundamental analysis of factors such as each issuer's financial condition and industry position, as well as market and economic conditions to select investments. The fund is non-diversified.

• Fund Family: Fidelity
• Category: Health
• Performance Rating: Average
• Risk Rating: Above Average
• Stock Exchange: Nasdaq
• Ticker Symbol: FBIOX
• Index: S&P 500 TR

Performance

FBIOX had a total return of 32.34% in the past year, including dividends. Since the fund's inception, the average annual return has been 12.81%.

Top 10 Holdings

44.32% of assets

Name	Symbol	Weight
AbbVie Inc.	ABBV	10.40%
Krystal Biotech, Inc.	KRYS	10.30%
Amgen Inc.	AMGN	6.98%
Moderna, Inc.	MRNA	3.49%
Insmed Incorporated	INSM	2.41%
Revolution Medicines, Inc.	RVMD	2.40%
argenx SE	ARGX	2.32%
Praxis Precision Medicines, Inc.	PRAX	2.29%
Ascendis Pharma A/S	ASND	2.01%
Natera, Inc.	NTRA	1.72%

Dividend History

Ex-Dividend	Amount	Pay Date
Apr 10, 2026	$1.063	Apr 13, 2026
Dec 12, 2025	$0.559	Dec 15, 2025
Apr 11, 2025	$0.062	Apr 14, 2025
Dec 13, 2024	$0.166	Dec 16, 2024
Apr 12, 2024	$0.063	Apr 15, 2024
Dec 27, 2023	$0.002	Dec 28, 2023

Data Sources: Tiingo, Financial Modeling Prep, and more

Historical data is provided by Tiingo. Delayed stock pricing data is provided by Financial Modeling Prep. Several fund data points are also provided by Finnhub.

Last checked:

Nov 9, 2026

Data Sources Report a data error